MorphoSys AG buy Adolf38
Summary
This prediction ended on 10.01.14 with a price of €62.66. The prediction had a final performance of 10.13%. Adolf38 has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | -0.075% | -0.075% | 216.051% | -0.015% |
| iShares Core DAX® | 2.749% | 4.620% | 17.121% | 21.210% |
| iShares Nasdaq 100 | 0.470% | -0.331% | 37.776% | 57.865% |
| iShares Nikkei 225® | -2.930% | -5.556% | 12.185% | 8.407% |
| iShares S&P 500 | 0.679% | 0.631% | 28.996% | 48.197% |
Comments by Adolf38 for this prediction
In the thread Morphosys AG diskutieren
Erneute Anhebung des Jahresziels
Das Biotechnologieunternehmen beschäftigt sich in erster Linie mit Forschungsaufgaben und
arbeitet mit vielen bekannten Pharmaunternehmen zusammen.Erneut wurde das Jahresziel angehoben.Der Kurs hat sich seit Anfang des Jahres fast verdoppelt.Ich werde die Aktie bei
nächster Gelegenheit kaufen,weil der Kurs weiter steigen wird.